WiseGuy Reports, Sept. 2025 (Press Release) – The Gene Therapy in Oncology Market Global Outlook:
Gene Therapy in Oncology Market Size, Share & Industry Analysis By Therapeutic Approach (Oncolytic Viral Therapy, Gene Transfer Techniques, Immune Modulation Therapy), By Application (Solid Tumors, Hematologic Malignancies, Targeted Gene Therapy), By Delivery Method (Viral Vectors, Non-Viral Vectors, CRISPR/Cas9), By Technology (Adenoviral Vectors, Lentiviral Vectors, Plasmid DNA) and Regional Forecasts, 2025-2032
Gene Therapy in Oncology Market Future Scope:
The future of the healthcare industry is set to be transformed by technology, innovation, and patient-centered care. Artificial intelligence and machine learning will enhance diagnostics, enabling earlier disease detection and personalized treatment plans. Telemedicine and digital health platforms will expand access to care, particularly in remote areas. Wearable devices and health apps will empower patients to monitor their well-being in real time. Precision medicine, driven by genomics, will create tailored therapies for individuals. Robotics and automation will streamline surgeries and hospital workflows. Sustainability and value-based care will remain key priorities, making healthcare more efficient, affordable, and patient-focused.
Request To Free Sample of This Strategic Report: https://www.wiseguyreports.com/sample-request?id=616334
Gene Therapy in Oncology Market Overview
Gene Therapy in Oncology Market: Transforming Cancer Treatment with Breakthrough Innovation
The Gene Therapy in Oncology Market is rapidly evolving as biopharmaceutical innovation and oncology advancements converge. With cancer cases rising globally and demand for personalized therapies accelerating, this market is projected to grow significantly, offering vast opportunities for stakeholders across the life sciences ecosystem.
Market Overview
The Gene Therapy in Oncology Market was valued at USD 7.3 billion in 2024 and is expected to reach USD 8.2 billion in 2025. By 2035, the market is forecasted to expand to USD 25.0 billion, registering a robust CAGR of 11.8% from 2025 to 2035. This rapid growth reflects the transformative role of gene-based therapies in precision oncology, alongside increasing R&D investment and supportive regulatory frameworks.
The market growth is driven by several dynamics, including the rising prevalence of cancer worldwide, technological progress in gene editing platforms, and the growing acceptance of innovative therapeutics among healthcare providers and patients.
Market Dynamics
The Gene Therapy in Oncology Market is shaped by multiple growth drivers:
- Rising cancer prevalence across both developed and emerging economies.
- Expanding R&D investments by pharmaceutical and biotech companies.
- Regulatory agencies offering favorable guidelines to accelerate clinical development.
- Growing awareness of personalized medicine and its benefits.
- Advancements in delivery methods, including viral and non-viral vectors.
Market Segmentation
The Gene Therapy in Oncology Market is segmented by therapeutic approach, application, delivery method, technology, and region.
- Therapeutic Approaches: Oncolytic virotherapy, gene transfer, and gene editing are key categories gaining traction.
- Applications: Therapies target hematologic malignancies, solid tumors, and rare cancers with high unmet needs.
- Delivery Methods: Viral vectors dominate, while non-viral delivery is witnessing rising adoption due to safety and scalability.
- Technology: CRISPR/Cas9, TALENs, and viral engineering platforms represent significant innovation pathways.
- Regional Landscape: North America leads due to strong regulatory support and research infrastructure. Europe follows with active adoption in Germany, UK, and France. APAC is emerging as a high-growth region, driven by China, Japan, and India.
You Can Purchase Complete Report: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=616334
Regional Outlook
- North America: The U.S. dominates with substantial R&D expenditure, robust clinical trials, and high adoption rates.
- Europe: Germany, UK, and France drive the region’s growth, supported by public-private funding and progressive health systems.
- APAC: China and Japan are key growth engines with rising biotech investments and regulatory advancements.
- South America: Brazil and Mexico are showing increasing adoption through partnerships with multinational pharma firms.
- MEA: GCC countries and South Africa are gradually expanding their oncology gene therapy landscape.
Competitive Landscape
- Novartis – advancing CAR-T therapies.
- Pfizer – expanding oncology-focused collaborations.
- Roche and Bristol Myers Squibb – leveraging precision oncology strategies.
- Amgen, Johnson & Johnson, and Gilead Sciences – strengthening clinical trial portfolios.
- Emerging innovators like Rocket Pharmaceuticals, Celyad Oncology, bluebird bio, and Sangamo Therapeutics are shaping the niche with advanced gene editing and transfer technologies.
Opportunities Ahead
The Gene Therapy in Oncology Market presents vast opportunities for stakeholders:
- Growing cancer incidence worldwide ensures sustained demand.
- Gene editing innovations such as CRISPR accelerate therapy development.
- Expanding clinical trial initiatives validate safety and efficacy.
- Rising investment in biotech startups enhances innovation pipelines.
- Increased awareness of personalized medicine strengthens adoption.
Browse In-depth Market Research Report (Pages, Charts, Tables, Figures): https://www.wiseguyreports.com/reports/gene-therapy-in-oncology-market
Avail This Gene Therapy in Oncology Market Language Pages Here:
腫瘍学における遺伝子治療の市場規模 | Marktanteile der Gentherapie in der Onkologie | Analyse du marché de la thérapie génique en oncologie | 종양학 시장 분석에서의 유전자 치료 | 肿瘤基因治疗市场概览 | Tendencias del mercado de la terapia génica en oncología
Other Related Reports from WiseGuy Research References
Batteries for Hearing Aid Market | 補聴器用電池市場規模 | Marktanteil von Hörgerätebatterien | Analyse du marché des piles pour appareils auditifs | 보청기용배터리시장분석 | 助听器电池市场概况 | Tendencias del mercado de baterías para audífonos
Bismuth Tripotassium Dicitrate Market | 二クエン酸三カリウムビスマス市場規模 | Marktanteil von Wismuttrikaliumdicitrat | Analyse du marché du dicitrate tripotassique de bismuth | 비스무트삼칼륨디시트레이트시장분석 | 柠檬酸铋三钾市场概况 | Tendencias del mercado de dicitrato de bismuto y tripotasio
Block Graft Market | ブロックグラフト市場規模 | Marktanteil von Blockgraft | Analyse du marché des greffes en blocs | 블록그래프트시장분석 | 阻断移植市场概览 | Tendencias del mercado de injertos en bloque
Cardiac Medication Market | 心臓病治療薬市場規模 | Marktanteil von Herzmedikamenten | Analyse du marché des médicaments cardiaques | 심장약시장분석 | 心脏药物市场概况 | Tendencias del mercado de medicamentos cardíacos
Calcitonin Salmon Injection Market | カルシトニンサーモン注射剤市場規模 | Marktanteil von Calcitonin-Lachs-Injektionen | Analyse du marché des injections de calcitonine au saumon | 칼시토닌연어주사제시장분석 | 鲑鱼降钙素注射液市场概况 | Tendencias del mercado de inyección de calcitonina de salmón
Clotting Factor Products Market | 凝固因子製品市場規模 | Marktanteil von Gerinnungsfaktorprodukten | Analyse du marché des produits à base de facteurs de coagulation | 응고인자제품시장분석 | 凝血因子产品市场概览 | Tendencias del mercado de productos de factor de coagulación
C-Myc Antibody Market | C Myc抗体市場規模 | Marktanteil von C-Myc-Antikörpern | Analyse du marché des anticorps C Myc | C Myc 항체시장분석 | C Myc 抗体市场概览 | Tendencias del mercado de anticuerpos C Myc
Chlorophyll Supplements Market | クロロフィルサプリメント市場規模 | Marktanteil von Chlorophyll-Ergänzungsmitteln | Analyse du marché des suppléments de chlorophylle | 엽록소보충제시장분석 | 叶绿素补充剂市场概览 | Tendencias del mercado de suplementos de clorofila
Cellular Therapy Products Market | 細胞療法製品市場規模 | Marktanteil von Zelltherapieprodukten | Analyse du marché des produits de thérapie cellulaire | 세포치료제품시장분석 | 细胞治疗产品市场概览 | Tendencias del mercado de productos de terapia celular
Ceruloplasmin Antibody Market | セルロプラスミン抗体市場規模 | Marktanteil von Coeruloplasmin-Antikörpern | Analyse du marché des anticorps anti-céruloplasmine | 세룰로플라스민항체시장분석 | 铜蓝蛋白抗体市场概览 | Tendencias del mercado de anticuerpos contra la ceruloplasmina
Chlamydia Diagnosis Treatment Market | クラミジア診断治療市場規模 | Marktanteil der Chlamydien-Diagnose-Behandlung | Analyse du marché du diagnostic et du traitement de la chlamydia | 클라미디아진단치료시장분석 | 衣原体诊断治疗市场概况 | Tendencias del mercado de diagnóstico y tratamiento de clamidia
About US:
Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets
